Targeted incentives for innovation-driven research would further strengthen India’s biotech ecosystem Read more
Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation Read more
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment Read more